265 related articles for article (PubMed ID: 26838210)
1. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.
Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B
Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma.
Terashi T; Aishima S; Taguchi K; Asayama Y; Sugimachi K; Matsuura S; Shimada M; Maehara S; Maehara Y; Tsuneyoshi M
Liver Int; 2004 Feb; 24(1):38-45. PubMed ID: 15101999
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
4. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
6. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
7. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma.
Zhang KJ; Zhang BY; Zhang KP; Tang LM; Liu SS; Zhu DM; Zhang DL
World J Gastroenterol; 2010 May; 16(20):2554-7. PubMed ID: 20503457
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
Kojima S; Hisaka T; Midorikawa R; Naito Y; Akiba J; Tanigawa M; Yano H; Akagi Y; Okuda K
Anticancer Res; 2020 Aug; 40(8):4749-4754. PubMed ID: 32727801
[TBL] [Abstract][Full Text] [Related]
12. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
13. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M
Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985
[TBL] [Abstract][Full Text] [Related]
14. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of 'scirrhous-type' and 'nonscirrhous-type' growth.
Kajiyama K; Maeda T; Takenaka K; Sugimachi K; Tsuneyoshi M
Am J Surg Pathol; 1999 Aug; 23(8):892-902. PubMed ID: 10435558
[TBL] [Abstract][Full Text] [Related]
15. The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma.
Aishima S; Taguchi K; Sugimachi K; Asayama Y; Nishi H; Shimada M; Sugimachi K; Tsuneyoshi M
Int J Surg Pathol; 2002 Jan; 10(1):47-56. PubMed ID: 11927969
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation.
Chuensumran U; Saelee P; Punyarit P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
[TBL] [Abstract][Full Text] [Related]
18. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
19. The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.
Tian X; Wang Q; Li Y; Hu J; Wu L; Ding Q; Zhang C
Pathol Oncol Res; 2015 Jan; 21(1):195-201. PubMed ID: 24985031
[TBL] [Abstract][Full Text] [Related]
20. Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome.
Byrling J; Sasor A; Nilsson J; Said Hilmersson K; Andersson R; Andersson B
Scand J Gastroenterol; 2020 Jun; 55(6):725-731. PubMed ID: 32543919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
